Gene expression profiling of CD133-positive cells in coronary artery disease

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 7512-7516

  Li, Jiayu ^a   Zhou, Changyu ^a   Li, Jiarui ^b   Wan, Yingchun ^a   Li, Tao ^a   Ma, Piyong ^a   Wang, Yingjian ^a   Sang, Haiyan ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Provincial Tumor Hospital   (China)

Author keywords

Coronary artery disease; Differentially expressed genes; Functional enrichment analysis; Gene expression profiles; Small molecules

Indexed keywords

CD133 ANTIGEN; PHOSPHODIESTERASE III; PROTEIN KINASE C ALPHA; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TRANSCRIPTOME;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORT; HUMAN; TREATMENT DURATION; BLOOD; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; KINESIOTHERAPY; METABOLISM;

ANTIGENS, CD; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; EXERCISE THERAPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLYCOPROTEINS; HUMANS; PEPTIDES; TRANSCRIPTOME;

EID: 84943617420     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4359     Document Type: Article

References (32)

1. Landmesser U and Drexler H: Chronic heart failure: An overview of conventional treatment versus novel approaches. Nat Clin Pract Cardiovasc Med 2: 628-638, 2005.
2. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH and Capewell S: Explaining the decrease in U-S. deaths from coronary disease, 1980-2000. N Engl J Med 356: 2388-2398, 2007.
3. Landmesser U, Wollert KC and Drexler H: Potential novel pharmacological therapies for myocardial remodeling. Cardiovasc Res 81: 519-527, 2009.
4. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, et al: Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783, 2006.
5. Segers VF and Lee RT: Stem-cell therapy for cardiac disease. Nature 451: 937-942, 2008.
6. Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, Van Camp G, Franken PR, Roland J, Van Riet I and Everaert H: Evidence that intracoronary-injected CD13+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp Hematol 35: 1884-1890, 2007.
7. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G and Wijns W: Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 112: I178-I183, 2005.
8. Ahmadi H, Baharvand H, Ashtiani SK, Soleimani M, Sadeghian H, Ardekani JM, Mehrjerdi NZ, Kouhkan A, Namiri M, Madani-Civi M, et al: Safety analysis and improved cardiac function following local autologous transplantation of CD133+ enriched bone marrow cells after myocardial infarction. Curr Neurovasc Res 4: 153-160, 2007.
9. Klein H, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR, Piechaczek C, Feifel N, Stockschlaeder M, Burchardt ER, et al: Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10: E66-E69, 2007.
10. Bonanno G, Mariotti A, Procoli A, Corallo M, Rutella S, Pessina G, Scambia G, Mancuso S and Pierelli L: Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial-and cardiomyocyte-like cells. Transfusion 47: 280-289, 2007.
11. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM and Dimmeler S: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622, 2004.
12. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J and Simm A: Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42: 2073-2080, 2003.
13. Liu D, Glaser AP, Patibandla S, Blum A, Munson PJ, McCoy JP, Raghavachari N and Cannon RO: Transcriptional profiling of CD133(+) cells in coronary artery disease and effects of exercise on gene expression. Cytotherapy 13: 227-236, 2011.
14. Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE and Sogayar MC: Evaluating different methods of microarray data normalization. BMC Bioinformatics 7: 469, 2006.
15. Smyth GK: Limma: Linear models for microarray data. In: Bioinformatics and computational biology solutions using R and Bioconductor. Springer, pp397-420, 2005.
16. Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological) 289-300, 1995.
17. Kolde R: Pheatmap: Pretty heatmaps. R package version 0-6 1: 2012.
18. Huang DW, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
19. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
20. Catania A, Urban S, Yan E, Hao C, Barron Gand Allalunis-Turner J: Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells. Neuro Oncol 3: 89-98, 2001.
21. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, et al: PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004.
22. Hambleton M, York A, Sargent MA, Kaiser RA, Lorenz JN, Robbins J and Molkentin JD: Inducible and myocyte-specific inhibition of PKCalpha enhances cardiac contractility and protects against infarction-induced heart failure. Am J Physiol Heart Circ Physiol 293: H3768-H3771, 2007.
23. Hambleton M, Hahn H, Pleger ST, Kuhn MC, Klevitsky R, Carr AN, Kimball TF, Hewett TE, Dorn GW 2nd, Koch WJ and Molkentin JD: Pharmacological-and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation 114: 574-582, 2006.
24. Rohr S, Bit-Avragim N and Abdelilah-Seyfried S: Heart and soul/PRKCi and nagie oko/Mpp5 regulate myocardial coherence and remodeling during cardiac morphogenesis. Development 133: 107-115, 2006.
25. Sun B, Li H, Shakur Y, Hensley J, Hockman S, Kambayashi J, Manganiello VC and Liu Y: Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice. Cell Signal 19: 1765-1771, 2007.
26. Saito Y, Kondo H and Hojo Y: Granzyme B as a novel factor involved in cardiovascular diseases. J Cardiol 57: 141-147, 2011.
27. Stout-Delgado HW, Getachew Y, Rogers TE, Miller BC and Thiele DL: The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity. Hepatology 46: 1530-1540, 2007.
28. Bird CH, Blink EJ, Hirst CE, Buzza MS, Steele PM, Sun J, Jans DA and Bird PI: Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol Cell Biol 21: 5396-5407, 2001.
29. Fayad W, Rickardson L, Haglund C, Olofsson MH, D'Arcy P, Larsson R, Linder S and Fryknas M: Identification of agents that induce apoptosis of multicellular tumour spheroids: Enrichment for mitotic inhibitors with hydrophobic properties. Chem Biol Drug Des 78: 547-557, 2011.
30. Kisselev AF, van der Linden WA and Overkleeft HS: Proteasome inhibitors: An expanding army attacking a unique target. Chem Biol 19: 99-115, 2012.
31. Zheng Q, Su H, Tian Z and Wang X: Proteasome malfunction activates macroautophagy in the heart. Am J Cardiovasc Dis 1: 214-226, 2011.
32. Stangl K, Gunther C, Frank T, Lorenz M, Meiners S, Ropke T, Stelter L, Moobed M, Baumann G, Kloetzel PM and Stangl V: Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun 291: 542-549, 2002.